Table 1

Demographic profiles of patient groups at baseline. Results are shown as mean (SEM)

Study 1 (hypertriglyceridaemic patients)
Group A (BZB) (n=13)Group B (ALL) (n=14)
Age (years)50.4 (2.7)50.5 (2.3)
BMI (kg/m2)24.3 (0.6)25.5 (0.8)
T-chol (mmol/l)5.60 (0.20)5.86 (0.18)
TG (mmol/l)2.87 (0.34)3.04 (0.44)
HDL-chol (mmol/l)1.17 (0.08)1.30 (0.06)
S-Cr (μmol/l)78 (4)70 (3)
Study 2 (hypertensive patients)
Group A (BZB) (n=13)Group B (ALL) (n=12)
BZB, benzbromarone; ALL, allopurinol; BMI, body mass index; T-chol, total cholesterol; TG, triglyceride; HDL-chol, high density lipoprotein cholesterol; S-Cr, serum creatinine; SBP, systolic blood pressure; DBP, diastolic blood pressure.
Age (years)54.4 (1.5)53.7 (2.2)
BMI (kg/m2)24.8 (0.6)24.7 (0.7)
SBP (mm Hg)160.0 (3.1)161.1 (4.2)
DBP (mm Hg)100.7 (2.4)101.2 (1.3)